Chronic Kidney Disease (CKD)
64
9
19
32
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.1%
2 terminated out of 64 trials
94.1%
+7.5% vs benchmark
13%
8 trials in Phase 3/4
28%
9 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 32 completed trials
Clinical Trials (64)
ESA Hyporesponsiveness in Hemodialysis Patients
A Retrospective Real-World Cohort Study
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
The CPH-MBD Cohort
Pramipexole and the Risk of Serious Adverse Events
Sertraline and the Risk of Serious Adverse Events
Lorazepam and the Risk of Serious Adverse Events
Escitalopram and the Risk of Serious Adverse Events
Citalopram and the Risk of Serious Adverse Events
Domperidone and the Risk of Serious Adverse Events
Tamsulosin and the Risk of Serious Adverse Events
Trace Element Imbalances in Dialysis Patients With CKD: the Role of Hemodialysis
Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
Do Endocrine Disruptors Accumulate in Children Undergoing Paediatric Dialysis?
Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure
Assessment of Dietary Balance in Home-Dwelling Patients With Stage 4 and 5 Chronic Kidney Disease Using URIKI (IKI), a Connected Urine Test Strip and In Vitro Diagnostic Medical Device
Patient-centered Precision Medicine Lab Result Communication for Older Adults
Remote vs In-Person Prehabilitation for Kidney Transplant Candidates
Epidemiological Cluster Evaluation in Patients Admitted to Internal Medicine, With at Least One of the Following Diagnoses: Heart Failure, COPD, Renal Failure. The FADOI IN-CluDiMI Study